-
Most Recent

Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Recent Healthcare Stocks Articles
Why Is Durect (DRRX) Stock Down 64% Today?
Durect stock is taking a beating on Wednesday as DRRX investors react to results from a Phase 2b clinical trial of larsucosterol.
Why Is Heart Test Laboratories (HSCS) Stock Up 298% Today?
Heart Test Laboratories stock is rising higher on Tuesday with heavy trading of HSCS despite a lack of news concerning the company.
BMRN Stock Jumps 12% as Activist Elliott Targets BioMarin Pharmaceuticals
Shares of BMRN stock are on the move today as activist investor Elliott Investment Management builds a position in this drugmaker.
Your Smartest Buys Now: The Top 7 Bargain Stocks to Buy in November
Are you looking for the smartest buys in November? Here are the top seven bargain stocks to buy in November.
Why Is TransMedics (TMDX) Stock Up 53% Today?
TransMedics stock is taking off on Tuesday as TMDX investors react to strong revenue and a guidance increase in its Q3 earnings report.
Why Is PaxMedica (PXMD) Stock Up 95% Today?
PaxMedica stock is taking off with heavy trading of PXMD shares following positive results from a Phase 2 clinical trial.
Why Is Ventyx Biosciences (VTYX) Stock Down 76% Today?
Ventyx Biosciences stock is taking a beating on Tuesday after the company announced it will end development of VTX958 on Phase 2 results.
Why Is Tharimmune (THAR) Stock Up 113% Today?
Tharimmune stock is gaining with heavy trading of THAR shares after the company announced an exclusive worldwide licensing agreement.
Why Is Senti Biosciences (SNTI) Stock Up 140% Today?
Senti Biosciences stock is rising higher on Tuesday as SNTI shares see heavy trading on a strategic collaboration announcement.
3 Biotech Moonshots to Bet on the Future of Health
Thanks to their potential blockbuster drugs, these three biotech stocks may yield huge returns for patent investors willing to take the risk.